Stock Comparison

NUVB vs REGN

Nuvation Bio Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

NUVB

Nuvation Bio Inc

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$2.14B

$80.55B

P/E (TTM)

—

19.4

Forward P/E

—

17.1

Price/Sales

12.6

5.2

Price/Book

8.5

2.5

EV/EBITDA

2.1

13.1

Dividend Yield

—

0.45%

Profitability

Net Margin

-102.06%

29.65%

Operating Margin

-104.99%

24.32%

Return on Equity

-47.80%

14.00%

Return on Assets

-12.40%

6.53%

Growth (YoY)

Revenue Growth

556.00%

16.70%

Earnings Growth

0.00%

-4.50%

Price & Risk

Beta

1.5

0.2

52-Week High

$9.54

$810.12

52-Week Low

$2.69

$553.38

Analyst Target

$12.89

$833.54

Compare NUVB and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.